KLK3 and posterior cortical atrophy: Based on these results and given the potential short- and long-term side effects associated with adjuvant radiotherapy [10,11], salvage and early-salvage approaches represent the preferred treatment choice for PCa patients whose prostate-specific antigen (PSA) levels remain high after RP and for those who develop biochemical recurrence (BCR) [12].